Russia's Internet giant Yandex together with a British-Swedish drug company AstraZeneca and the Russian Society of Clinical Oncology will launch a platform for cancer diagnostics through DNA testing, the Kommersant newspaper reported Tuesday.
The platform, called RAY, is designed to improve the methods of cancer diagnostics and detect a person's predisposition to cancer, Kommersant reported, citing an unidentified Yandex representative and AstraZeneca spokeswoman Marina Rozhdestvina.
The cancer diagnostics platform is the first experience in the field of medicine by Yandex Data Factory, Yandex's division providing big data-processing services.
The program analyzes the uploaded results of DNA testing, generates a report about the found mutations in the genome of the patients, and provides information on its possible effects and recommendations on treatment.
The testing of the platform will begin in December. If testing is successful, RAY will become a paid service. However, some of its elements, such as the mutation database of Russian patients, will probably be available to the medical community for free, Yandex's representative told the paper.
A Message from The Moscow Times:
Dear readers,
We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."
These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.
We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.
Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.
By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.
Remind me later.